Review summarizes aggressiveness of interval cancers across screening programs

Most interval cancers detected between screening rounds—including lung, breast, and colorectal—exhibit high aggressiveness and poor prognosis, highlighting limitations in current screening strategies.

• Interval cancers are more biologically aggressive than screen-detected cancers.
• Artificial intelligence is being explored to improve screening sensitivity and reduce interval cancer rates.
• The review calls for optimized screening protocols and personalized multidisciplinary planning.

Automated summary

RadPigeon summaries are original and for information only. They are not clinical advice.